New study tests if checking in from home can improve cancer care

NCT ID NCT07024329

Recruiting now Symptom relief Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program where cancer patients report symptoms from home using a digital questionnaire. A nurse monitors the results and provides advice between clinic visits. The goal is to see if this improves quality of life and reduces emergency room visits and hospital stays. Over 1,000 patients will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remote symptom monitoring and management program
What this could lead to: If successful, this could improve cancer patients' quality of life and reduce emergency visits and hospital stays by catching symptoms early.
What could go wrong: This is a large implementation study, not a drug trial. The benefit may be modest and depend on patient engagement. Results may not apply to all cancer types or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm Patient Acceptance of Health Care

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Arthur J. E. Child Comprehensive Cancer Centre
RECRUITING

Calgary, Alberta, T2N 4N1, Canada
Central Alberta Cancer Centre
RECRUITING

Red Deer, Alberta, T4N 6R2, Canada
Cross Cancer Institute
RECRUITING

Edmonton, Alberta, T6G 1Z2, Canada
High River Community Cancer Centre
NOT_YET_RECRUITING

High River, Alberta, T1V 1B3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.